Company intelligence / Profile preview

Visioneering Technologies

Alpharetta, Georgia, United Statesvtivision.com ↗

Ownership: Private
Development stage: Other

Overview

Visioneering Technologies has commercialized its flagship product, the NaturalVue Multifocal 1 Day contact lens. The product has demonstrated substantial performance improvements over existing multifocal lenses and has been adopted by practitioners for both presbyopia in adults and myopia management in children. The company reports strong early adoption among eye care professionals.

Therapeutic areas: Ophthalmology
Modalities: Device (Contact lens)
Industry: Assistive Medical Devices

Partnerships

None publicly disclosed as of June 2025.

Beyond the preview

Go deeper on Visioneering Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Visioneering Technologies.

Explore the full profile